Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
3370465 | Journal of Clinical Virology | 2009 | 4 Pages |
Abstract
In four of five HIV-1 and HIV-2 dually infected patients treated with efavirenz-based therapy, viral load was undetectable for HIV-1 only, with limited increase in CD4+ counts. Both viral loads were undetectable and CD4+ counts increased in one patient treated with protease inhibitor regimen. Specific guidelines for treating HIV-dually infected patients are needed that should avoid the use of non-nucleoside reverse transcriptase inhibitors.
Related Topics
Life Sciences
Immunology and Microbiology
Applied Microbiology and Biotechnology
Authors
Marie-Yolande Borget, Karidia Diallo, Christiane Adje-Toure, Terence Chorba, John N. Nkengasong,